Motz Stephan A, Schaefer Ulrich F, Balbach Stefan, Eichinger Thomas, Lehr Claus-Michael
Saarland University, Biopharmaceutics and Pharmaceutical Technology, Saarbrücken, Germany.
Eur J Pharm Biopharm. 2007 May;66(2):286-95. doi: 10.1016/j.ejpb.2006.10.015. Epub 2006 Oct 28.
The aim of our study was to develop an apparatus assessing in vitro permeation through Caco-2 monolayers of oral solid dosage forms as a possible tool to forecast in vivo performance. Therefore, flow through dissolution and permeation modules were connected by means of a stream splitter. Permeation was measured in a specially designed cell, dissolution took place in the apparatus 4, USP. In order to test the apparatus for its reproducibility and conclusiveness, different tablet strengths and varying release profiles of propranolol HCl tablets were produced and evaluated. It was shown that for both tablet species, immediate and extended release, the apparatus was able to measure permeation through Caco-2 monolayer as well as dissolution simultaneously with high precision and reproducibility. The permeated amount of the three immediate release tablets with increasing dosage strength showed linear dependency on the dosage strength. Furthermore, the effect of retarded release on permeation could be detected and conclusive data for dissolution and permeation were obtained. In summary, connecting cell culture based permeability assessment with compendial flow through dissolution equipment led to promising results and poses the base for more advanced studies for detecting influences of dosage forms on permeation process.
我们研究的目的是开发一种装置,用于评估口服固体剂型通过Caco-2单层的体外渗透情况,作为预测体内性能的一种可能工具。因此,流通式溶出模块和渗透模块通过分流器连接。渗透在一个专门设计的细胞中进行测量,溶出在USP装置4中进行。为了测试该装置的重现性和结论性,制备并评估了不同片剂强度和不同释放曲线的盐酸普萘洛尔片。结果表明,对于速释片和缓释片这两种片剂类型,该装置能够高精度、可重现地同时测量通过Caco-2单层的渗透以及溶出情况。三种不同剂量强度的速释片的渗透量随剂量强度增加呈线性相关。此外,还能检测到缓释对渗透的影响,并获得了溶出和渗透的结论性数据。总之,将基于细胞培养的渗透性评估与药典规定的流通式溶出设备相结合,取得了有前景的结果,并为更深入研究剂型对渗透过程的影响奠定了基础。